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The regenerative ability of CNS axons decreases with age, how-
ever, this ability remains largely intact in PNS axons throughout
adulthood. These differences are likely to correspond with age-
related silencing of proteins necessary for axon growth and elon-
gation. In previous studies, it has been shown that reintroduction
of the 9 integrin subunit (tenascin-C receptor, 9) that is down-
regulated in adult CNS can improve neurite outgrowth and sensory
axon regeneration after a dorsal rhizotomy or a dorsal column
crush spinal cord lesion. In the current study, we demonstrate that
virally expressed integrins (9, 6, or 1 integrin) in the adult rat
sensorimotor cortex and adult red nucleus are excluded from
axons following neuronal transduction. Attempts to stimulate
transport by inclusion of a cervical spinal injury and thus an
upregulation of extracellular matrix molecules at the lesion site, or
cotransduction with its binding partner, 1 integrin, did not induce
integrin localization within axons. In contrast, virally expressed 9
integrin in developing rat cortex (postnatal day 5 or 10) demon-
strated clear localization of integrins in cortical axons revealed by
the presence of integrin in the axons of the corpus callosum and
Significance Statement
Most CNS neurons have an intrinsically low ability to regenerate their axons. This study has asked whether
the transport into axons of integrins, the receptors that mediate growth through extracellular matrix, might
reveal reasons for the poor regenerative ability of CNS axons. Tagged integrins were expressed in sensory,
retinal ganglion cell, cortical, and red nucleus neurons. The integrins were transported down the axons of
sensory and retinal ganglion cell axons, but not down the axons of adult cortical or red nucleus neurons.
However, during the postnatal period of corticospinal axon growth, cortical neurons admitted integrins into
their axons. The findings suggest that exclusion of integrins and other receptors from CNS axons may be
a cause for their poor regenerative ability.
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internal capsule, as well as in the neuronal cell body. Furthermore, examination of dorsal root ganglia neurons and
retinal ganglion cells demonstrated integrin localization both within peripheral nerve as well as dorsal root axons
and within optic nerve axons, respectively. Together, our results suggest a differential ability for in vivo axonal
transport of transmembrane proteins dependent on neuronal age and subtype.
Key words: adeno-associated virus; axon initial segment; dorsal root ganglia; integrin; retinal ganglion cell;
sensorimotor cortex
Introduction
Deficiencies in the regeneration of adult CNS axons are
due to several factors including inhibitory molecules in the
lesion environment and a neuronal regenerative response
that diminishes with neuronal maturation. Previously, in-
tegrin biology has been studied as a window into mech-
anisms of axon regeneration and their failure with
maturation (Andrews et al., 2009; Eva et al., 2010, 2012;
Tan et al., 2011; Franssen et al., 2015). Integrins are
heterodimeric transmembrane proteins that bind extracel-
lular matrix (ECM) molecules to induce cell proliferation,
survival, and promote outgrowth (Hynes, 2002). These
proteins are an integral part of CNS development, but
many become downregulated in neurons upon CNS mat-
uration (Hammarberg et al., 2000; Andrews et al., 2009).
Consequently, when either integrins or their ligands are
downregulated, axon growth fails. Specifically, when
adult dorsal root ganglia (DRG) neurons are grown on
marginal ECM substrates such as low levels of laminin
and fibronectin, neurite outgrowth requires forced expres-
sion of 1 integrin and 5 integrin, respectively (Condic,
2001). It is therefore of interest that 91, the integrin that
recognizes tenascin-C, the main extracellular matrix gly-
coprotein of the adult CNS, is developmentally downregu-
lated. Following CNS injury, there is a substantial
upregulation of tenascin-C without a concurrent upregu-
lation of 9 integrin (Zhang et al., 1997; Tang et al., 2003;
Andrews et al., 2009). As a strategy to induce axon re-
generation in the CNS, this integrin has been re-
expressed in the CNS. This allows sensory axons to grow
prolifically on tenascin-C in vitro but addition of inhibitory
substrates such as CSPGs and Nogo, as occurs in vivo,
blocks this growth through inactivation of integrins (Tan
et al., 2011). Forced activation of integrins can allow
axons to overcome this inhibition (Hu and Strittmatter,
2008; Tan et al. 2011). By increasing the pool of 9
integrin in DRG neurons using adeno-associated virus
(AAV), a modest increase in the regenerative response at
the site of injury after dorsal rhizotomy and after a dorsal
column spinal cord lesion has been demonstrated (An-
drews et al., 2009). In addition, expression of the integrin
activator kindlin-1 in DRG neurons only promotes limited
regeneration in the spinal cord, whereas coexpression of
9 and kindlin promotes extensive regeneration and ro-
bust functional recovery (Tan et al., 2011; Cheah et al.,
2016). An obvious next step is to use this combination to
promote regeneration of intrinsic CNS axons. However, in
vitro studies suggest that this strategy may fail because of
the exclusion of integrins from CNS axons as they mature
(Franssen et al., 2015).
Clearly, integrins can only stimulate axon regeneration if
they are present in the axon at the site of damage. In the
current study, we have asked whether integrins are trans-
ported into sensory axons including DRG and retinal gan-
glia neurons (RGCs), and into several types of adult
neurons including adult cortical neurons, rubrospinal neu-
rons, and we also evaluated early postnatal cortical neu-
rons during their growth phase. This study has been
enabled by improvements in viral technology that have
made it possible to produce AAV vectors that can accom-
modate epitope-tagged full-length integrins. We show
here that the presence in axons of virally expressed in-
tegrins in vivo is dependent upon neuronal type as well as
age. Integrins are restricted to the cell body and dendrites
of adult cortical and rubrospinal neurons whereas during
the developmental growth period, we observed integrins
in the axons of early postnatal cortical neurons. However
in adult RGC and DRG neurons, which have better regen-
erative ability especially following conditioning lesions,
integrins were present along the length of the axons.
These results suggest that in two important pathways
involved in motor control known to be incapable of axonal
repair, integrins become excluded from the axons as they
mature.
Materials and Methods
Integrin viral constructs
cDNAs encoding wild-type 9 integrin were obtained
from Dean Sheppard (University of California San Fran-
cisco) as previously described (Andrews et al., 2009).
cDNAs encoding wild-type 6 and 1 integrins and
eGFP-N1 vectors were obtained from Charles ffrench-
Constant (University of Edinburgh, UK) and cDNAs en-
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coding 1 integrin-GFP were obtained from Martin
Humphries (University of Manchester, UK). pcDNA3.1/V5-
His was purchased from Invitrogen. cDNA of 6 and 9
integrin was cloned into eYFP-N1 using HindIII and KpnI
restriction sites. V5 was PCR amplified adding on the AgeI
and NotI restriction sites before being cloned into the
a9integrin-eYFP plasmid upon removal of eYFP. Integrin
lentiviral plasmids were constructed by PCR amplifying
BclI and SacII onto the 6integrin-eYFP, 9integrin-eYFP,
and 1integrin constructs, before cloning into the LV-PGK
vector (Bensadoun et al., 2003). Integrin AAV plasmids
using a short CAG promoter or a CMV promoter were
constructed by inserting the tagged integrin constructs
between the ITRs of AAV2 followed by a short poly-
adenylation signal (49bp).
Generation of viruses
Lentiviruses
The production, generation, and titration of lentiviral
particles for LV-PGK-9-eYFP, LV-PGK-6-eYFP, LV-
PGK-1integrin, and LV-PGK-eGFP was performed with
a four-plasmid system as previously described (Bensa-
doun et al., 2003).
Adeno-associated viruses
The production and titration of AAV serotype 2 and 5
vector particles for AAV5-CAG-9integrin-V5, AAV5-CMV-
9integrin-eYFP, AAV2-CAG-9integrin-V5, and AAV5-
1integrin-eGFP was performed as previously described
(Fagoe et al., 2015). Briefly, a typical batch of AAV was
produced in six 15 cm Petri dishes of HEK293T cells
cultured in DMEM) containing 10% fetal calf serum and
1% penicillin/streptomycin. Transfer and helper plasmids
were mixed in a ratio of 1:3 and cotransfected using
polyethylenimine (linear MW 250,000, Polysciences).
Three days post-transfection cells were harvested in Dul-
becco’s PBS (Invitrogen) and lysed by three freeze-thaw
cycles. Genomic DNA was digested by adding DNAse I
(Roche Diagnostics) and the AAV vector particles were
purified from the crude lysate by the iodixanol gradient
method (Hermens et al 1999; Zolotukhin et al 1999) and
concentrated using an Amicon 100 kDa Ultra-15 device
(Millipore). Concentrated AAV stocks were stored at
80oC until use. Titers (genomic copies/ml) were deter-
mined by quantitative PCR of viral DNA using primers
against the CMV-enhancer sequence (Table 1).
Surgeries
Experiments were conducted in accordance with the
UK Animals (Scientific Procedure) Act, 1986. Adult male
Sprague-Dawley rats (250–400 g) were used for all corti-
cal injections (adult and neonate), red nucleus injections,
and intravitreal injections whereas adult male Lewis rats
(250–400 g) were used for all DRG injections (Charles
River Laboratories) (Table 2). Food and water were pro-
vided ad libitum and there was 12 h light/dark exposure.
During surgery, adult rats were anesthetized in 1–2%
isoflurane, in 2 L/min oxygen.
Cortical and red nucleus injections: adult
Adult cortical injection groups (LV-PGK-6integrin-
eYFP, n3; LV-PGK-9integrin-eYFP, n3; LV-PGK-
eGFP, n5; AAV5-CAG-9integrin-V5, n5; AAV-CAG-
1integrin-GFP, n6) sustained a single injection of 1l
LV or AAV into the left forelimb sensorimotor cortex (SMC)
Table 1. List of viruses produced and used for procedures
Virus Area injected Serotype if AAV
LV-PGK-9integrin-eYFP Cortex —
LV-PGK-6integrin-eYFP Cortex —
LV-PGK-eGFP Cortex —
LV-PGK-1integrin Cortex —
AAV-CMV-9integrin-eYFP DRG 5
AAV-CAG-9integrin-V5 Retina 2
AAV-CAG-9integrin-V5 Cortex, DRG 5
AAV-CAG-1integrin-GFP Cortex 5
Table 2: List of animal groups with viral type used
Area of injection and age Virus No. of animals
SMC – Neonate LV-PGK-9integrin-eYFP n9
SMC – Neonate LV-PGK-eGFP n10
SMC – Adult LV-PGK-9integrin-eYFP n3
SMC – Adult LV-PGK-6integrin-eYFP n3
SMC – Adult LV-PGK-eGFP n5
SMC – Adult LV-PGK-9-eYFP LV-PGK-1 n9
SMC – Adult AAV5-CAG-9integrin-V5 n5
SMC – Adult AAV5-CMV-1integrin-GFP n6
SMC – Adult AAV5-CAG-9-V5  AAV5-CMV-1-eGFP n10
SMC – Adult  SCI LV-PGK-9integrin-eYFP n3
SMC – Adult  SCI LV-PGK-6integrin-eYFP n6
SMC – Adult  SCI LV-PGK-eGFP n4
Red Nucleus – Adult LV-PGK-6integrin-eYFP n3
Red Nucleus – Adult LV-PGK-eGFP n3
Red Nucleus – Adult  SCI LV-PGK-9integrin-eYFP n3
Red Nucleus – Adult  SCI LV-PGK-6integrin-eYFP n6
Red Nucleus – Adult  SCI LV-PGK-eGFP n5
DRG – Adult AAV5-CAG-9integrin-eYFP n8
DRG – Adult AAV5-CAG-9integrin-V5 n6
Retina AAV2-CAG-9integrin-V5 n10
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at (AP 1.5 mm, ML 1.5 mm, DV 1.5mm; Krajacic et al.,
2009). Red nucleus injection groups (LV-PGK-6integrin-
eYFP, n3; LV-PGK-9integrin-eYFP, n3; LV-PGK-
eGFP, n3) sustained a single injection of LV into the left
red nucleus at (AP 5.9 mm, ML 0.7 mm, DV 7.0 mm).
Injections were performed using a custommade 30 gauge
stainless steel needle attached to a Hamilton syringe
driven by an infusion syringe pump (World Precision In-
struments) at 0.2 l/min. One microliter was injected into
the left SMC (LV or AAV) or into the left red nucleus (LV)
over a 5 min period, followed by a 3 min period before
needle withdrawal.
Cortical injection: neonates
Neonatal cortical injections (LV-PGK-9integrin-eYFP,
n9; LV-PGK-eGFP, n10) were conducted under hypo-
thermic anesthesia with a single manual injection of 1 l of
LV into the developing left SMC at the following coordi-
nates: ML 1.0 mm, AP 0.5 mm, DV 0.7 mm (Altman
and Bayer, 1995), over the course of 1–2 min, followed by
a 1 min period before needle withdrawal. Pups were
returned to their mother immediately following the proce-
dure. Half of each group was taken for immunohisto-
chemical analysis at 5 or 10 d postinjection.
Dorsal root ganglia injection
DRG injections were performed as described previously
with some variations (Andrews et al., 2009). Briefly, under
anesthesia, a left hemilaminectomy was performed at
cervical levels C5–C6 (AAV5-CMV-9-eYFP, n8) to uni-
laterally expose the C5–C6 DRG and dorsal roots or at
lumbar levels L4–L5 (AAV5-CAG-9-V5, n8) to unilater-
ally expose the L4–L5 DRG and dorsal roots. One micro-
liter injections were performed as described for the adult
cortical injections except with a 33 gauge stainless steel
needle attached to a Hamilton syringe driven by an infu-
sion syringe pump at a rate of 0.1 l/min, followed by a 3
min period before needle removal.
Spinal cord lesions
Cervical dorsal column crush lesions at C4–C5 were per-
formed as previously described (Andrews et al., 2009) con-
current with the cortical injection. Briefly, under anesthesia
(LV-PGK-6integrin-eYFP, n6; LV-PGK-9integrin-eYFP,
n3; LV-PGK-eGFP, n4), a laminectomy was performed
at cervical levels C4 and C5 to expose the dorsal surface of
the spinal cord. The dura was retracted and the dorsal
columns, identified within the immediate extents of the
dorsal root entry zones on either side, were crushed
bilaterally for 10 s using finely-milled forceps at a depth of
2 mm. With regard to cervical lateral hemisection lesions
at C4–C5 (LV-PGK-6integrin-eYFP, n6; LV-PGK-
9integrin-eYFP, n3; LV-PGK-eGFP, n5), access to
the spinal cord was performed as described above. Fol-
lowing dura retraction and identification of dorsal roots, a
scalpel blade was inserted into the spinal cord rostral to
the root entry to a depth of 2mm with the cut extending
laterally to the edge of the cord.
Intravitreal injections
Injections were performed as described previously (Bull
et al., 2012). Briefly, under isoflurane anesthesia with local
anesthestic applied topically to the cornea of the left eye,
the left eyelid was gently retracted. Five microliters of
AAV2-CAG-9integrin-V5 (n10 animals) was injected
into the vitreous of the left eye using a using a custom
made 30 gauge stainless steel needle attached to a Ham-
ilton syringe. Care was taken during the injection to en-
sure the lens was not damaged. The needle remained in
position for 1 min following injection before needle with-
drawal.
Immunohistochemistry
At the end of each experimental time point, animals
were administered an overdose of sodium pentobarbital
and transcardially perfused with PBS, pH 7.4, followed by
4% PFA, pH 7.4. Tissues (including brain, spinal cord,
eyes, optic nerves, DRG, dorsal roots, and sciatic nerves
depending on the paradigm) were removed and postfixed
in 4% PFA and cryoprotected overnight in 30% sucrose in
0.1 M PB, pH 7.4.
Brain, spinal cord, dorsal roots, sciatic nerves, and gan-
glia
Brain tissue was sectioned coronally on a sliding mi-
crotome at a thickness of 40 m and stored in PBS with
0.02% sodium azide at 4°C until further processing and
analysis. Spinal cord tissue was embedded in OCT
(RALamb UK) and sectioned longitudinally (spinal cord) or
transversely with spinal cord attached (for dorsal roots,
ganglia, and sciatic nerves) on a cryostat at 14 m thick-
ness, mounted on slides (Superfrost Plus, VWR Interna-
tional) and stored at 20°C until further processing and
analysis.
Sections were washed with PBS and blocked in 10%
NGS, 0.4% TX-100 in PBS. Primary antibodies, anti-3
tubulin (1:400, mouse; Sigma-Aldrich), anti-GFP (1:500,
rabbit; Molecular Probes), anti-V5 (1:250, mouse; Invitro-
gen), anti-GFAP (1:400, mouse; Sigma-Aldrich), anti-
ankyrin G (1:100, mouse; Neuromabs), anti-ankyrin G (1:
100, rabbit; Santa Cruz Biotechnology), anti-tenascin C
(1:200, mouse; IBL America), anti-collagen IV (1:500, rab-
bit; Sigma-Aldrich), anti-fibronectin (1:100, rabbit; Sigma-
Aldrich), and anti-laminin (1:500, rabbit; Sigma-Aldrich)
were incubated overnight at 4°C. Sections were rinsed in
triplicate in 0.1 M PBS and incubated with secondary
antibodies (1:500, goat anti-mouse or rabbit AlexaFluor
568 or 488; Invitrogen), followed by a brief incubation with
bisbenzimide (Sigma-Aldrich) nuclear stain. Slides were
rinsed and coverslipped with Fluorosave. Certain antibod-
ies (anti-tenascin C, anti-ankyrin G) required amplification
using streptavidin. In these cases, pretreatment of the
tissue with 0.3% H2O2 for 30 min was performed, along
with incubation with biotinylated goat anti-rabbit or anti-
mouse antibodies (1:500, Vector Laboratories) used in
place of fluorescent secondary antibodies. Tissue was
then incubated with streptavidin-conjugated to AlexaFluor
568 (1:250, Invitrogen).
Retinal whole mounts and optic nerve processing
Animals were perfused as described above and the
eyes, optic nerve and brains were removed and postfixed
overnight in 4% paraformaldehyde at 4°C. For retinal
whole mounts, retinas from both eyes were dissected and
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prepared as flattened whole mounts by making four radial
cuts (Bull et al., 2012). Retinal tissue was further postfixed
overnight as above. Following PBS washes, tissue was
incubated in blocking buffer (5% normal goat serum,
0.2% triton X-100 in PBS) prior to incubation overnight at
4°C in primary antibodies (rabbit anti-tubulin, 1:1000, Co-
vance; mouse anti-V5, 1:250, Invitrogen) diluted in block-
ing buffer. Following further PBS washes, tissue was
incubated overnight at 4°C in secondary antibodies (goat
anti-mouse 488 and goat anti-rabbit 568, 1:750, Invitro-
gen) diluted in blocking buffer. Following the final PBS
washes, retinal tissue was mounted on microscope slides
and coverslipped with Fluorosave. For optic nerve sec-
tions, optic nerves were cryoprotected in 30% sucrose,
embedded in OCT embedding media, cryosectioned lon-
gitudinally at a thickness of 14 m and mounted onto
Superfrost Plus microscope slides. Optic nerve sections
were processed as described above for spinal cord cryo-
sections using anti-V5 and anti-3 tubulin antibodies.
Microscopy and analysis
Fluorescence imaging was performed using a Leica
DM6000 epifluorescent microscope, a Leica TCS SP2,
and a Leica SP8 confocal microscope. Images were cap-
tured using LAS AF Leica software, and processed with
Adobe Photoshop CS4.
Results
Axons are transported into the axons of developing
postnatal cortical neurons
Integrins are vital for CNS development including neu-
ronal migration and axonal elongation (Graus-Porta et al.,
2001; Denda and Reichardt, 2007), so it would be ex-
pected that they would be transported to advancing ax-
onal growth cones. We therefore examined axonal
localization of integrins during the immediate postnatal
period when certain classes of axons such as the corti-
cospinal tract are still undergoing development and elon-
gation. Initially, we used many integrin antibodies, but
were unable to find one that demonstrated sufficiently
good staining of endogenous integrins in tissue sections
to show unequivocally whether or not integrins are pres-
ent in classes of CNS axons. We therefore transduced
neurons with tagged integrins that have been used previ-
ously in in vitro transport studies and which traffic nor-
mally in cellular vesicles to and from the cell surface (Eva
et al. 2010, 2012; Franssen et al. 2015). Lentiviruses with
their large cloning capacity (8 kB) were used in this
study because they allow for expression of a fluorescently
tagged, full-length integrin and have been shown to suc-
cessfully transduce cortical neurons in vivo achieving
maximum expression levels as early as 5–10 d (Hutson
et al., 2012). In this group, we injected a lentivirus encod-
ing eYFP-tagged 9 integrin under the control of a phos-
phoglycerate kinase promoter (LV-PGK-9-eYFP) into the
sensorimotor cortex of rat pups on the day of birth (P0)
and assessed axonal localization 5 or 10 d later (P5 and
P10; Fig. 1A). These early time points were selected
based on minimal time required for in vivo lentiviral trans-
duction and gene expression and the time window during
which corticospinal tract (CST) axonal elongation is still
ongoing. Results from this group demonstrated high lev-
els of neuronal transduction illustrated by colabeling of
NeuN and eYFP at the injection site, as early as 5 d
postinjection (Fig. 1B,C). Quite strikingly at P5, we also
observed eYFP-tagged 9 integrin localized in axons
Figure 1. eYFP-tagged 9 integrin is transported into early postnatal cortical axons. Schematic of experimental design indicating the
ages at which the lentivirus was injected and the time points of perfusion and tissue analysis (A). Fluorescent images of cortical
injection site 5 d following LV-PGK- 9integrin-eYFP injection showing eYFP-labeled cortical neurons (green; B) colabeled with NeuN
(red) and bisbenzimide nuclear label (blue; C). Fluorescent images of eYFP-labeled 9integrin within axons of the corpus callosum (D)
or internal capsule (E), 5 or 10 d following cortical injection, respectively. F, Coronal brain illustrations (left) indicate approximate area
of injection site (of boxed area for B, C) and area of image of corpus callosum (in D) and (right) indicate approximate area of image
of internal capsule (in E). Scale bars: B, C, 100 m; D, E, 50 m.
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within the corpus callosum (Fig. 1D), whereas at P10 we
observed YFP-tagged 9 integrin within axons of the
internal capsule (Fig. 1E). In both cases, the localization
was characterized by a punctate and vesicular appear-
ance of the eYFP-tagged integrin (Fig. 1D,E).
Adult DRG neurons transport integrins into both
peripheral and central axons
We next investigated the presence of tagged 9 integrin in
the axons of adult DRG neurons. For these experiments,
we used AAV serotype 5 to achieve optimal transduction
of DRG neurons because lentivirus will not transduce
DRG neurons in vivo (Mason et al., 2010). Recently mod-
ified AAV plasmids (including plasmids with deleted
WPRE sequences and small polyA sequences) made it
possible to clone full-length 9 integrin fused to either an
eYFP or V5 epitope tag. Cervical or lumbar DRG were
injected with either AAV5-CMV-9-eYFP or AAV5-CAG-
9-V5, respectively, and analyzed 3–6 weeks postinjec-
tion. We saw a high level of integrin within the cell bodies
and in the axons within the DRG (Fig. 2A–C). After injec-
tion into the L4 and L5 lumbar DRG, examination of the
sciatic nerve revealed clear localization of V5-tagged 9
integrin within peripheral axons (Fig. 2D–F). Likewise, ex-
amination of the central branch of the DRG, the dorsal
root, revealed V5-tagged 9 integrin localized within these
axons extending toward the spinal cord (Fig. 2G–I). Within
the dorsal root entry zone, eYFP-tagged 9 integrin could
be observed having reached and entered the spinal cord
extending along the dorsal columns following injection
into the C5 and C6 DRG (Fig. 2J,K).
Adult optic nerve axons contain integrins
RGCs share some similarities with DRG in their response
to injury and their regenerative ability, specifically with
regard to the conditioning lesion response, including the
significantly enhanced growth response following a pe-
ripheral preconditioning lesion (Leon et al., 2000). They
also both respond to treatment with cyclic AMP (cAMP;
Monsul et al., 2004). We therefore asked whether adult
RGCs would transport integrin into optic nerve axons
similar to DRG. In these experiments, intravitreal injec-
tions in adult rat were performed unilaterally using a se-
rotype 2 AAV (AAV2-CAG-9-V5), which is the optimal
AAV serotype for transducing RGCs (Hellström et al.,
2009). Three weeks postinjection we observed trans-
duced cell bodies of retinal ganglia neurons along with
axonal fibers colocalizing 9 integrin and 3 tubulin within
axons extending toward the optic disc, as well as trans-
port into the branching dendrites (Fig. 3A,C). Within the
retina, we were able to see integrin transported into the
axons of all the brightly transduced RGCs. Further exam-
ination into the optic nerve 3 weeks postinjection revealed
the presence of 9 integrin-V5 as punctate vesicles
throughout the length of some axons (Fig. 3B) including
the presence of integrin in axons up to the chiasma
resulting from this relatively short-term (3 weeks) experi-
ment.
Virally expressed integrin does not enter the axons
of adult cortical neurons or adult red nucleus
neurons
To further assess axonal localization of virally expressed
integrins in the CNS, we initially used lentivirus for in vivo
neuronal transduction of adult cortical neurons. Unilateral
injections into adult rat sensorimotor cortex resulted in a
region of transduced neurons with either LV-PGK-6-
eYFP (Fig. 4C) or LV-PGK-9-eYFP (Fig. 6F). This was
comparable to the transduction efficiency found with in-
jections of LV-PGK-eGFP (Fig. 4A). Upon examination of
the cervical spinal cord, many GFP-filled corticospinal
axons were visible in the LV-eGFP group (Fig. 4B). On the
other hand, there was no indication of eYFP-tagged in-
tegrin in corticospinal axons in the cervical spinal cord
expressing either 6 (Fig. 4D) or 9 integrin (data not
shown). Assessment of the corticospinal tract more prox-
imal to the injection site revealed no tagged integrin at any
point. At the injection site, eYFP-tagged integrin (9 in-
tegrin) was present in the cell body, dendrites, and in
some proximal axonal processes of the transduced cor-
tical neurons (Fig. 5B–D). In these cases, 9 integrin-eYFP
could be localized within apical dendrites extending to-
ward the outer layers of the cortex (Fig. 5C), and in some
cases the labeling could be seen in dendritic spines (Fig.
5D). We saw no integrin transport beyond the proximal
processes of the neurons, including the subcortical white
matter or anywhere further down the corticospinal tract.
To confirm that the lack of integrin transport into adult
CST axons was not due to experimental parameters of
viral type (LV), viral promoter (PGK), or the large eYFP tag
(722 base pairs) attached to the integrins, we repeated
these experimental groups with consideration of these
parameters. In these cases, we used AAV with an alter-
native promoter, CAG, and the small V5 epitope tag (42
base pairs) fused to the integrin (AAV-CAG-9-V5). For
these experiments, AAV5 was used as it has been shown
to successfully transduce cortical neurons (Hutson et al.,
2012), as well as other neuronal subtypes (Mason et al.,
2010). Following adult cortical injections using AAV5-
CAG-9-V5, a larger and more diffuse area of neuronal
transduction at the injection site was observed compared
with LV, however, an absence of axonal localization of
integrins beyond the proximal process of the axon re-
mained (Fig. 5A). To show that this selective transport
pattern is not restricted to alpha integrins, we also in-
jected AAV-CAG-1-eGFP, an AAV vector encoding
tagged 1 integrin, and showed the same localization with
transport into dendrites but no transport down axons (Fig.
5E–G). Normal intracellular trafficking of integrins requires
the presence of the  heterodimers in order to be cor-
rectly transported from the endoplasmic reticulum
through the Golgi to the plasma membrane (Tiwari et al.,
2011). It is currently unclear how much 1 integrin, the
binding partner of 9 integrin and 6 integrin, is ex-
pressed in adult cortical neurons in vivo despite its pres-
ence being documented in hippocampal and cerebellar
neurons (Pinkstaff et al., 1999), and in neurons of the red
nucleus demonstrated by in situ hybridization (Plantman
et al., 2005). To examine whether cotransduction of 9
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integrin and 1 integrin had an effect on axonal localiza-
tion, we introduced both subunits by performing com-
bined injections into adult rat cortex. These were
performed in two groups: (1) LV-PGK-9-eYFP and LV-
PGK-1 (untagged), and (2) AAV5-CAG-9-V5 and AAV5-
CAG-1-eGFP. We saw no change to the overall
localization of the eYFP- or V5-tagged 9 integrin, with
integrins remaining in the cell body and dendrites (data
not shown). We conclude that, in agreement with our
previous observations in vitro (Franssen et al., 2015) in-
Figure 2. V5 and eYFP-tagged 9 integrin expressed in DRG neurons is transported to the central and peripheral branches of DRG
axons. DRG neurons express 9 integrin-V5 (green in all panels) 4 weeks following injection of AAV5-CAG-9integrin-V5 into the L4
and L5 DRG (A) including within the proximal neuronal processes (C, arrows), shown colabeled with 3 tubulin (red) (B). Confocal (D)
and epifluorescent (E) images show V5-labeled 9 integrin within axons in the sciatic nerve, 4 weeks following DRG injection,
colabeled with anti-3 tubulin (red; F). Confocal (G) and epifluorescent (H) images show V5-labeled 9 integrin within axons in the
dorsal root, 4 weeks following DRG injection, colabeled with anti-3 tubulin (red) (I). Epifluorescent image of eYFP-labeled 9 integrin
(J, K, green) in the axons of the dorsal root entry zone leading into the dorsal column, 6 weeks following DRG injection of
AAV-CMV-9integrin-eYFP into the C5 and C6 DRG (J), and in axons in the dorsal columns (K, arrows) observed in sagittal section
at level C2 (K). Scale bars: A, B, J, K, 200 m; C, E, F, H, I, 100 m; D, G, 20 m.
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tegrins in mature cortical neurons are excluded from ax-
ons, but transported into dendrites (Fig. 5A–E).
Investigation within another motor tract in the adult, the
rubrospinal tract (RST), revealed a similar pattern. Follow-
ing lentiviral injections into the red nucleus of adult rat
there were many neurons expressing high levels of GFP
from LV-eGFP and LV-integrin (6) injections (Fig. 4E–H).
Examination of the rubrospinal tract in the cervical spinal
cord revealed GFP-filled axons in the LV-eGFP group (Fig.
4F), although there was no indication of any eYFP-tagged
integrin localizing in rubrospinal axons (Fig. 4H).
One of the main requirements for integrins to induce
intracellular signaling and downstream cellular processes
such as neurite outgrowth is for ligand binding to occur
with ECMmolecules (Reichardt et al., 1989; Hynes, 2002).
In the above experimental groups, cortical injections were
performed in uninjured naïve adult animals in the absence
of an injury-induced upregulation of ECM, thus, although
tenascin-C is present in the uninjured adult CNS, it could
be suggested that transport into axons did not occur due
to a lack of an ECM-stimulus, or that integrin transport
might only occur after an axotomy. To address this issue,
we performed cortical injections of LV-PGK-9-eYFP or
LV-PGK-6-eYFP along with a concurrent dorsal column
crush spinal lesion at C4/C5 injuring the CST. Alterna-
tively, we also performed red nucleus injections of LV-
PGK-9-eYFP with a concurrent lateral overhemisection
lesion at C4/C5 injuring the RST. Following spinal cord
lesions there is a large increase in ECM molecules includ-
ing tenascin-C, the ligand for 91 integrin (Andrews
et al., 2009), and other ECM molecules such as collagen,
fibronectin, and laminin, a ligand for 61 integrin (Fig.
6A–D). These cervical lesions did not result in the pres-
ence at the injury site of 6 integrin or 9 integrin in CST
axons (Fig. 6E) or of integrins in RST axons (data not
shown). Instead in these cases, we observed a similar
localization of integrins within the cell bodies and den-
drites at the injection site (Fig. 6F). To rule out distance as
a factor influencing integrin transport to the injury site, a
further group with a nearby cortical stab injury was in-
cluded, but these cases also showed no axonal localiza-
tion to the injury site (data not shown).
There has been mounting evidence in the literature
suggesting that the axon initial segment (AIS) acts as a
selective barrier, only permitting some classes of mole-
cules to access the axon (Song et al., 2009; Franssen
et al., 2015). Although the role of the AIS in the localization
of sodium channels is established, there was also some
evidence in our in vitro study that the AIS might present a
developmental barrier for molecules, such as integrins
(Franssen et al., 2015; Normand and Rasband, 2015).
Immunohistochemical analysis using antibodies against
ankyrinG was performed on naïve early postnatal cortex
(P3) and adult cortex. Results demonstrated that at both
ages, ankyrinG-immunopositive structures were present
in the axons of the cortex (Fig. 7A–C). Immunostaining for
ankyrinG and 9 integrin-V5 in virally injected adult cortex
showed that in many neurons integrins did not enter the
Figure 3. 9integrin-V5 expressed in adult RGCs is transported into optic nerve axons. Confocal images of flat mount retina show
RGCs immunolabeled with anti-V5 (green) and colabeled with anti-3 tubulin (red) 3 weeks after intravitreal injection of AAV2-CAG-
9integrin-V5 (A, C). A, A high magnification image (from A) of integrin-containing axons in a fascicle (arrows) travelling toward the
optic nerve. Epifluorescent images in B of optic nerve indicate V5-labeled 9integrin within axon fibers of the optic nerve 3 weeks
following AAV injection. Arrows in C indicate V5-labeled axons following along the course of 3 tubulin axons. Scale bars: A, C, 20
m; B, 50 m.
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initial segment, whereas in others there was some integrin
in the proximal-most part of the axon, colocalizing with
ankyrinG (Fig. 7D–F). In the cortex, therefore, the AIS is
present at a time point when integrins are localized within
axons (early postnatally) suggesting that ankyrinG by itself
is not the barrier to axonal transport of integrins or equally
that there is a developmental regulation of this barrier that
occurs between early postnatal development and adult-
hood.
Discussion
This study has focused on the axonal localization of virally
expressed integrin receptors in vivo. The work was stim-
ulated by demonstrations that expression of appropriate
integrins can drive a growth response in damaged neu-
rites and axons (Condic et al., 1999; Condic, 2001; An-
drews et al., 2009). In particular, it has been shown that
expression of the integrin 9, the receptor for tenascin-C,
Figure 4. 6Integrin expressed in adult cortical or rubrospinal neurons is not transported down CST or RST axons. Adult motor cortex
3 weeks following injection of LV-PGK-eGFP (A) or LV-PGK-6integrin-eYFP (C). In cervical spinal cord, axons are filled with eGFP
in the CST following LV-PGK-eGFP cortical injection (B), but no integrins are observed after LV-PGK-6integrin-eYFP injection (D).
C, High magnification view of LV-6 integrin transduced cortical neurons. Adult red nucleus 3 weeks following injection of
LV-PGK-eGFP (E) or LV-PGK-6integrin-eYFP (G). Within the cervical spinal cord, only in the LV-PGK-eGFP injected groups are RST
fibers found labeled with GFP (F) and not following LV-PGK-6integrin-eYFP injection (H). Scale bars: A, C, E, G, 500 m; B, D, 100
m; F, H, 200 m.
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can enhance the intrinsic regenerative response of sen-
sory axons in the spinal cord. Transduction of DRG with
9 integrin, particularly if accompanied by the integrin
activator kindlin-1, enables cut axons to regenerate
through the inhibitory tenascin-rich extracellular milieu of
the damaged spinal cord (Andrews et al., 2009; Tan et al.,
2012; Cheah et al., 2016). However, a recent in vitro study
on cortical neurons indicated that integrins (both endog-
enous and expressed) are excluded from their axons as
they mature (Franssen et al., 2015), suggesting that over-
expression of integrin by itself will not stimulate regener-
ation of the axons of cortical neurons. In these CNS
neurons, the mechanisms controlling transport into axons
will also have to be addressed. In this study, we have
addressed the issue of integrin distribution in vivo. We
have expressed a variety of integrins in sensory neurons
and three CNS neuronal types to see whether or not they
are excluded from axons. We used viral-mediated ex-
pression of tagged integrins for two reasons. This is an
established regeneration-inducing strategy and because
integrin antibodies stain tissue sections poorly, potentially
due to low endogenous expression levels in the adult
CNS. We show that axonal localization of virally ex-
pressed integrins is highly dependent on neuronal type
and age. Young cortical neurons during their growth
phase as well as adult sensory and retinal ganglion cell
neurons permit virally expressed integrins into their ax-
ons, whereas axons of adult motor (cortical and red nu-
cleus) neurons do not contain integrins. Rather in the
latter cases, integrins remain within the somatodendritic
compartment, sometimes entering the very proximal
axons where they coincide with the ankyrinG-immuno-
positive axon initial segment. Our finding in the rubrospi-
nal tract is somewhat surprising due to published data
that demonstrates that RST axons have been shown to
regenerate for short distances into peripheral nerve
grafts following certain treatments including BDNF
(Kobayashi et al., 1997). These findings of integrin ex-
clusion from the axon however, remain consistent re-
gardless of viral type, viral promoter, integrin subunit,
fluorescent/epitope tag, and axotomy. This confirms in
vivo our previous in vitro findings that integrins are
transported into the axons of immature cortical neu-
rons, but are progressively excluded as the neurons
mature (Franssen et al., 2015), that integrins are trans-
ported freely into adult DRG axons (Eva et al., 2010,
Figure 5. 9Integrin- and 1integrin-transduced adult cortical neurons express integrins in their dendrites but not in their axons. 9-
and 1-transduced neurons (A–E) show prominent apical and basal dendrites (white arrows), but integrins have not entered the axon
beyond the very proximal processes (A, E, F). B, A region of cortex above the injection site demonstrating 9-transduced neurons
with YFP-immunopositive integrin within apical dendrites. C, Detail of YFP-immunopositive 9integrin dendritic arbors branching
(white arrows) near the surface of the cortex. D, A confocal image of YFP-immunopositive 9integrin within a dendrite with prominent
dendritic spines (white arrows). F, G, The base of the cortex and the underlying white matter 4 weeks following AAV5-1-GFP cortical
injections demonstrating transduction of neurons throughout a wide area of cortex. Most of the white matter is devoid of tagged
integrin, but a few fine processes of neurons very close to the white matter can be seen, demonstrating that labeled processes in white
matter can be seen if present. G, A composite showing subcortical white matter from the midline (left of picture) to lateral cortex.
Although there are many integrin-transduced neurons in the overlying cortex, no integrin-containing axons are observed in the white
matter of the corpus callosum. Scale bars: A, C, E, F, 50 m; B, G, 100 m; D, 10 m.
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2012), and that integrins can be detected in adult retinal
ganglion cell axons (Vecino et al., 2015).
The observation that integrin is transported into the
axons of two populations of sensory neurons, adult DRG
and RGC neurons, is interesting because both have a
relatively high intrinsic regenerative ability. For example,
following a (pre)conditioning lesion consisting of a periph-
eral nerve cut or crush (Richardson and Issa, 1984; Neu-
mann and Woolf, 1999) or lens injury (Leon et al., 2000),
both neuronal types have been found to have increased
levels of GAP-43 (growth-associated protein, 43 kDa) and
concurrently significant axon regeneration. Likewise, fol-
lowing neuronal application of cAMP, both axonal popu-
lations respond with increased growth after injury (Qiu
et al., 2002; Monsul et al., 2004). Both neuronal popula-
tions continue to express integrins at higher levels than
cortical neurons into adulthood (Vecino et al., 2015; Wer-
ner et al., 2000), so why do they not regenerate better in
the CNS environment when cut? We suggest two rea-
sons: first they do not express 9, the key integrin for
interacting with the CNS extracellular matrix, and second
any integrins present on their axons are inactivated by
CSPGs and by NogoA (Hu and Strittmatter 2008; Tan
et al., 2011). In support of these ideas, we have shown
prolific regeneration of sensory axons in the spinal cord
by transduction with 9 integrin and/or the integrin acti-
vator kindlin-1 (Andrews et al. 2009; Tan et al. 2012;
Cheah et al., 2016). In the combined study applying both
9 integrin and kindlin-1, we have shown integrin trans-
port into regenerating sensory axons in the dorsal column,
and the fact that integrin-stimulated regenerating axons
reached the medulla implies that active integrin was trans-
ported over this distance (Cheah et al., 2016).
Conversely, in our experiments with neurons in two
motor pathways, the corticospinal and rubrospinal tracts,
there was an obvious exclusion of integrins from axons.
These pathways are well known to show only very low
levels of regeneration following injury. Furthermore, nei-
ther a spinal cord injury-induced upregulation of ECM nor
dual expression of both alpha and beta subunits were
enough to stimulate transport in these axons. Likewise, in
spinal cord lesions, transported proteins have been
shown to accumulate at the terminals of cut axons (Ertürk
et al., 2007), so had the integrins been axonally trans-
ported in adult CST axons postinjury, they should have
accumulated and been present at the damaged axon
ends even if less dense integrins within the length of the
axons were below levels of detection. A correlation may
exist between the endogenous regenerative capacity of
axons and the ability of transmembrane receptors to lo-
calize/transport within axons. Moreover, it is not only
integrins that are excluded from these axons, but also
TrkB and IGFR (Hollis et al., 2009a,b). CNS axons appear
to become specialized for connectivity through selective
Figure 6. CNS injury induces upregulation of ECM expression but does not induce integrin localization in adult CST axons. Cervical
dorsal column crush lesion leads to upregulation of ECM molecules such as collagen (A), fibronectin (B), laminin (C), and tenascin-C
(D). Dashed lines in A–E indicate approximate borders of lesion site. Following injections of LV-9integrin-eYFP (E=) into adult
sensorimotor cortex with concurrent cervical spinal cord crush lesion did not induce CST axonal localization 3 or 6 weeks following
injury and injection (E). High magnification image (F) demonstrates perinuclear appearance of neuronally expressed 9 integrin
(arrowheads) also localized within dendrites (arrows). Scale bars: (in A) A–F, 100 m; F=, 200 m.
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transport of presynaptic molecules and exclusion of
growth-related molecules.
During the period of axon growth, integrins are impor-
tant for enabling growth cone advance (Denda and Reich-
ardt, 2007). It is therefore not surprising that we found that
integrins are transported into corticospinal axons during
their growth phase. At an early postnatal age, injection of
LV-PGK-9-eYFP in the sensorimotor cortex at postnatal
day (P)0 resulted in 9 integrin localization in a punctate
pattern within axons of the corpus callosum and the
internal capsule at day P5 and P10, respectively, during
which time axons are still elongating. It is also within this
early postnatal age group that CST axon regeneration is
possible following injury (Bates and Stelzner, 1993). The
developmental change from integrin transport to exclu-
sion correlates with a general age-related reduction in
axonal transport that occurs within both CNS and PNS
axons, which can be rescued in the PNS with a condition-
ing lesion (Milde et al., 2015).
For sensory neurons, a previous conditioning crush of
the peripheral nerve can increase the regenerative ability
of the central branch of the axons and stimulate local
regeneration in the spinal cord (Neumann and Woolf,
1999). Retinal axons in the optic nerve show little regen-
eration unless a lens lesion or modification of signaling is
applied (Leon et al. 2000; Sun et al. 2011). It will be
interesting to see whether these various interventions
alter integrin transport into axons. In the current work,
lesion of the corticospinal tract made no difference to
integrin transport into the axons. In the case of DRG
neurons, we have obtained long-distance regeneration in
the spinal cord of many axons with excellent sensory
recovery through expression of 9 integrin and the integ-
rin activator kindlin-1 in sensory neurons without needing
to make a conditioning lesion (Cheah et al., 2016).
Recent work has suggested mechanisms for axonal
transport and selective exclusion of integrins. In sensory
axons, integrins are transported in recycling vesicles
marked by the GTPases Rab11 and Arf6 (Eva et al., 2010)
and TrkB receptors in hippocampal neurons are associ-
ated with Rab11 (Huang et al., 2013). As cortical neurons
mature, Arf6 transport of integrins becomes retrograde,
acting to exclude integrins, driven by increases in the Arf6
GEFs, Efa6, and ARNO. Additionally, there are many stud-
ies that demonstrate that the axon initial segment acts as
a filter at the axon hillock between the cell body and axon,
allowing only select proteins to access the axonal com-
partment (Arnold, 2009; Song et al., 2009; Normand and
Rasband, 2015; Eva et al., 2012; Petersen et al., 2014).
However, our observation of the presence of an ankyrin
G-immunoreactive axon initial segment as early as P3 in
cortical neurons in vivo suggests that the AIS may exist
but has not developed a full barrier function at an early
age.
The findings in this study suggest differences in the
transport of transmembrane integrin receptors and their
subsequent localization within axons, which is dependent
on neuronal subtype and age. In order for integrin recep-
tors to induce a growth response, they have to be able to
interact with the ECM of the external lesion environment
and must therefore be transported to the tips of cut
axons. In DRG and RGC axons this appears to be the
case, and if transport into other CNS axons could be
enabled, there is a strong potential for an enhanced re-
generative response using integrin gene therapy.
Figure 7. Ankyrin G is expressed in both early postnatal (P3) and adult cortical neurons, with integrin localization apparent in the axon
initial segment in adult injection sites. Epifluorescent images of anti-ankyrin G immunolabeled cortex of adult (A) or P3 rat (B, C). B,
Inset, Higher magnification inC. D–F, Confocal images near an adult cortical injection site (AAV5-CAG-9-v5) with V5-immunopositive
9 integrin within neurons (D), colabeled with anti-ankyrin G (E), indicating that in some cases there was colocalization of
virally-expressed integrin with the ankyrin G-immunopositive axon initial segment. Scale bars: A, B, 100 m; C, 50 m; D–F, 10m.
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